Fasting Study of Ciprofloxacin Extended-Release Tablets 1000 mg and Cipro® XR Tablets 1000 mg

NCT00649662 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Ciprofloxacin Extended-Release Tablets 1000 mg
DRUG: Cipro® XR Tablets 1000 mg

Sponsor

Mylan Pharmaceuticals Inc